iRhythm/IRTC

$118.28

-0.12%
-
1D1W1MYTD1YMAX

About iRhythm

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Ticker

IRTC

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Quentin Blackford

Employees

2,000

Headquarters

San francisco, United States

iRhythm Metrics

BasicAdvanced
$3.29B
Market cap
-
P/E ratio
-$4.04
EPS
1.28
Beta
-
Dividend rate

What the Analysts think about iRhythm

Analyst Ratings

Majority rating from 12 analysts.
Buy

Price Targets

Average projection from 9 analysts.
17.61% upside
High $165.00
Low $132.00
$118.28
Current price
$139.11
Average price target

iRhythm Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-29.13% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$132.5M
6.34%
Net income
$-38.6M
42.44%
Profit margin
-29.13%
33.99%

iRhythm Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 35.1%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q1 24
Actual
-$1.29
-$0.61
-$0.89
-
Expected
-$0.90
-$0.78
-$0.66
-$0.96
Surprise
42.9%
-22.03%
35.1%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell iRhythm stock

Buy or sell iRhythm stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing